Revlon Group Holdings, LLCJanuary 12, 2024

FDA 483 - Revlon Group Holdings, LLC - January 12, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Revlon Group Holdings, LLC

Record Details

Revlon Group Holdings, LLC in Oxford, NC, received a Form 483 following an FDA inspection from January 8-12, 2024. The inspection revealed significant deficiencies in equipment cleaning and sanitation, laboratory controls for water testing, and line clearance procedures, indicating potential cross-contamination and product quality issues in their OTC drug manufacturing.

Company: Revlon Group Holdings, LLC
Inspection Date: January 12, 2024
Product Type: Drugs
Office: Atlanta District Office
Person: Martrice A. Packer (Program Coordinator)

Open in Dashboard

ID · 7f81f7b2-8bf2-4605-b54a-901ecf8e20c3